Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-10
2005-05-10
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
06890948
ABSTRACT:
Compounds of formula (I), or physiologically functional derivatives thereof, wherein: R1, R2, R3and R′3are independently selected from II or lower alkyl; and R4, R5, R6and R7are independently selected from H, electron withdrawing groups (such as F, Cl, Br, I, OCF3, carboxyl groups, acetal groups, electron deficient aryl groups), lower alkyl groups lower alkoxy groups, aryl groups or aryloxy groups, wherein it least one of R4, R5, R6, and R7is selected from an electron withdrawing group, may be used in methods of therapy, particular in treating neoplastic diseases in methods of GDEPT, ADPET, PDEPT and PDT
REFERENCES:
patent: 3689657 (1972-09-01), Share et al.
patent: 3901914 (1975-08-01), Hannah
patent: 5684034 (1997-11-01), Bach et al.
patent: 6017945 (2000-01-01), Rawson et al.
patent: WO 8807378 (1988-10-01), None
patent: 9414434 (1994-07-01), None
Wardman, P., “Indol-3-Acetic Acids and Horseradish Peroxidase: A New Prodrug/Enzyme Combination for Targeted Cancer Therapy,”Current Pharmaceutical Design,2002, , vol. 8, No. 15, pp. 1363-1374.
Rossiter, S., “A Convenient Synthesis of 3-Methyleneoxindoles: Cytoxic Metabolites of Indole-3-Acetic Acids,”Tetrahedron Letters,43, 2002, pp. 4671-4673.
Folkes, L., et al., “Reactivity Toward Thiols and Cytotoxicity of 3-Methylene-2-Oxindoles, Cytotoxins from Indole-3-Acetic Acids, on Activation by Peroxidases,”Chem. Res. Toxicol.,2002, vol. 15, No. 6, pp. 887-882.
Rossiter, S., et al., “Halogenated Indole-3-Acetic Acids as Oxidatively Activated Prodrugs with Potential for Targeted Cancer Therapy,”Bioorganic&Medicinal Chemistry Letters 12,2002, pp. 2523-2526.
Greco, O., et al., “Horseradish Peroxidase-Mediated Gene Therapy: Choice of Prodrugs in Oxic and Anoxic Tumor Conditions,”Molecular Cancer Therapeutics,vol. 1, Dec. 2001, pp. 151-160.
Folkes, L., et al., “5-Fluoroindole-3-Acetic Acid: A Prodrug Activated by a Peroxidase with Potential for Use in Targeted Cancer Therapy,”Biochemical Pharmacology,63, 2002, pp. 265-272.
Greco, O., et al., “Development of a Novel Enzyme/Prodrug Combination for Gene Therapy of Cancer:Horseradish Peroxidase/Indole-3-Acetic Acid,” Cancer Gene Therapy,vol. 7, No. 11, 2000, pp. 1414-1420.
Folkes, L., et al., “Oxidative Activation of Indole-3-Acetic Acids to Cytotoxic Species-A Potential New Role for Plant Auxins in Cancer Therapy,”Biochemical Pharmacology,61, 2001, pp. 129-136.
Connolly, C., et al., “Transport into and Out of the Golgi Complex Studied by Transfecting Cells with cDNAs Encoding Horseradish Peroxidase,”The Journal of Cell Biology,vol. 127, No. 3, Nov. 1994, pp. 641-652.
Ben-Yoseph, O., et al., “Oxidation Therapy: The use of a Reactive Oxygen Species-Generating Enzyme System for Tumour Treatment,”Br. J. Cancer,1994, vol. 70, pp. 1131-1135.
Edwards, A., et al., “Apoptosis Induction in Nonirradiated Human HL-60 and Murine NSO/2 Tumor Cells by Photoproducts of Indole-3-Acetic Acid and Riboflavin,”Photochemistry and Photobiology,1999, 70(4), pp. 645-649.
Laliberte, M., et al., “Sulface Modification of Horseradish Peroxidase with Poly(Ethylene Glycol)s of Various Relative Molecular Masses (Mr): Relationship between the Mrof Poly(Ethylene Glycol) and the Stability of Horseradish Peroxidase-Poly(Ethylene Glycol) Adducts under Various Denaturing Conditions,”Biotechnol. Appl. Biochem.20, 1994, pp. 397-413.
Hart, S., et al., “Lipid-Mediated Enhancement of Transfection by a Nonviral Integrin-Targeting Vector,”Human Gene Therapy,9, Mar. 1, 1998, pp. 575-585.
Fortier, G., et al., Surface Modification of Horseradish Peroxidase with Poly(Ethylene Glycol)s of Various Molecular Masses.Biotechnol. Appl. Biochem.,17, 1993, pp. 115-130, Great Britain.
Erdtman, H., et al., “Synthetic Plant Hormones,”Acta Chemica Scandinavica,8, 1954, No. 1, pp. 119-123.
Katz, A., et al., “Synthesis and Analgesic Activity of Pemedolac (cis-1-Ethyl-1,3,4,9-Tetrahydro-4-(Phenylmethyl)Pyrano[3,4-b]indole-1-Actic Acid,”Journal of Medicinic Chemistry,31, 1988, pp. 1244-1250.
Carrera, Jr., G., et al., “Synthesis of 6- and 7-Arylinodoles via Palladium-Catalyzed Cross-Coupling of 6-and 7-Bromoindole with Arylboronic Acids,”Synlett.Jan. 1994, pp. 93-94.
Dillard, R., et al.,“Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2-1 Indole-3-Acetamides,”J. Med. Chem.,39, 1996, pp. 5119-5136.
Fox, S., et al., “Synthesis of Indole-3-Acetic Acids and 2-Carboxyindole-3-Acetic Acids with Substituents in the Benzene Ring,”J. Am. Chem. Soc.,vol. 73, Jun. 1951, pp. 2756-2759.
Engvild, K., “Preparation of Chlorinated 3-Indolylacetic Acids,”Acta Chem. Scan. B.,31, No. 4, 1977, pp. 338-339.
Vasey, P., et al., “Phase I Clinical and Pharmacokinetic Study of PK1 [N-(2-Hydroxypropyl)Methacrylamide Copolymer Doxorubicin]: First Member of a New Class of Chemotherapeutic Agents-Drug-Polymer Conjugates,”Clinical Cancer Research,vol. 5, Jan. 1999, pp. 83-94.
Duncan, R., et al., “The Role of Polymer Conjugates in the Diagnosis and Treatment of Cancer,”S.T.P. Pharma Sciences,6 (4), 1996, pp. 237-263.
Samoszuk, M., et al.,“Targeting of Glucose Oxidase to Murine Lymphoma Allografts,”Tumor Targeting,1, 1995, pp. 37-43.
Bartoli, G., et al., “The Reaction of Vinyl Grignard Reagents with 2-Substituted Nitroarenes: A New Approach to the Synthesis of 7-Substituted Indoles,”Tetrahedron Letters,vol. 30, No. 16, 1989, pp. 2129-2132, Great Britain.
Bagshawe, K., et al., “Antibody-Enzyme Conjugates Can Generate Cytotoxic Drugs from Inactive Precursors at Tumor Sites,”Antibody, Immonoconjugates and Radiopharmaceuticals,vol. 4, No. 4, 1991, pp. 915-922.
Folkes, L., et al., “Peroxidase-Catalyzed Effects of Indole-3-Acetic Acid and Analogues on Lipid Membranes, DNA, and Mammalian Cells, in Vitro,”Biochemical Pharmacology,vol. 57, 1999, pp. 375-382.
Candeias, L., et al., “Amplification of Oxidative Stress by Decarboxylation: A New Strategy in Anti-Tumor Drug Design,”Biochemical Society Transactions,23, 1995, p. 262.
Job, D., et al., “Substituent Effect on the Oxidation of Phenols and Aromatic Amines by Horseradish Peroxidase Compound I,”Eur. J. Biochem.,66, 1976, pp. 607-614.
Still, C., et al., “Inhibitory Oxidation Products of Indole-3-Acetic Acid,”The Journal of Biological Chemistry,vol. 240, No. 6, Jun. 1965, pp. 2612-2618.
Fukuyama, T. et al., “Inhibition of Cell Growth by Photooxidation Products of Indole-3-Acetic Acid,”The Journal of Biological Chemistry,vol. 239, No. 7, Jul. 1964, pp. 2392-2397, U.S.A.
Mirsky, I., et al., “Hypoglycemic Action of Indole-3-Acetic Acid by Mouth in Patients with Diabetes Mellitus,”Proc. Soc. Exp. Biol. Med.,1956, pp. 109-110.
Pires de Melo, M., et al., “Peroxidase Activity May Play a Role in the Cytotoxic Effect of Indole Acetic Acid,”Photochemistry and Photobiology,65, (2), 1997, pp. 338-341.
Pires de Melo, M., et al., “Effect of Indole Acetic Acid on Oxygen Metabolism in Cultured Rat Neutrophil,”Gen. Pharmac.,vol. 31, No. 4, 1998, pp.573-578, U.S.A.
Huber, B., et al.,“Retroviral-Mediated Gene Therapy for the Treatment of Hepatocellular Carcinoma: An Innovative Approach for Cancer Therapy,”Proc. Natl. Acad. Sci.,vol. 88, Sep. 1991, pp. 8039-8043, U.S.A.
Culver, K., et al., “In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors,”Science,vol. 256, Jun. 12, 1992, pp. 1550-1552.
Dalton, S., et al., “Characterization of SAP-1, a Protein Recruited by Serum Response Factor to the c-fos Serum Response Element,”Cell.,vol. 68, Feb. 7, 1992, pp. 597-612.
Engelhardt, J., et al., “Direct Gene Transfer of Human CFTR into Human Bronchial Epithelia of Xenografts with E1-Deleted Adenoviruses,”Natur
Dachs Gabriele U.
Folkes Lisa
Greco Olga
Rossiter Sharon
Wardman Peter
Cancer Research Technology Limited
Foley & Lardner LLP
Henley III Raymond J.
LandOfFree
Use of indole-3-acetic acid derivatives in medicine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of indole-3-acetic acid derivatives in medicine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of indole-3-acetic acid derivatives in medicine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3434598